The effect of SETD2 mutation (mts) on histone 3 lysine 36 tri-methylation (H3K36me3) and correlation with clinical outcome in patients (pts) with metastatic clear cell renal cell carcinoma (ccRCC) enrolled in COMPARZ.

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.15_suppl.4583

Web Of Science Accession Number

Start Page

• 4583

End Page

• 4583

Volume

• 32

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2014

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.15_suppl.4583

Web Of Science Accession Number

Start Page

• 4583

End Page

• 4583

Volume

• 32

Issue

• 15_suppl

Place Of Publication